Boyer David W. bought NBIX
February 13, 2026 · Form 4 insider transaction
Boyer David W. bought 5,479 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,479
Price
$0.00
Total value
N/A
InsiderBoyer David W.
Role—
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateFebruary 13, 2026
Filing dateFebruary 17, 2026
Shares owned after5,479
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each RSU represents a contingent right to receive one share of the Issuer's common stock .; The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030.